Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Renbing Jiang
Xinjiang Medical University - Affiliated Cancer Hospital
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
34
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety and Efficacy of Pucotenlimab (HX008) - A Humanized Immunoglobulin G4 Monoclonal Antibody in Patients with Locally Advanced or Metastatic Melanoma: A Single-Arm, Multicenter, Phase II Study
Number of pages: 9
Posted: 02 Jun 2022
Chuanliang Cui
,
Yu Chen
,
Zhiguo Luo
,
Zhengyun Zou
,
Yu Jiang
,
Hongming Pan
,
Qingxia Fan
,
Jianfu Zhao
,
Qing Xu
, Renbing Jiang,
Xuan Wang
,
Taiyang Ma
,
Zhen Guo
,
Lu Si
,
Zhihong Chi
,
Xinan Sheng
,
Yiwei Dou
,
Qian Tan
,
Di Wu
and
Jun Guo
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Fujian Medical University - Fujian Cancer Hospital, Fudan University - Shanghai Cancer Center (FUSCC), Nanjing University - The Affiliated Drum Tower Hospital, Sichuan University - West China Hospital, Zhejiang University - Sir Run Run Shaw Hospital, The First Affiliated Hospital of Zhengzhou University, Jinan University, Tongji University - Shanghai Tenth People's Hospital, Xinjiang Medical University - Affiliated Cancer Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Taizhou Hanzhong Biomedical Co., Ltd. (A member of Lepu Biopharma Co., Ltd.), Jilin University (JLU) - First Hospital, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Taizhou Hanzhong Biomedical Co., Ltd. (A member of Lepu Biopharma Co., Ltd.), Taizhou Hanzhong Biomedical Co., Ltd. (A member of Lepu Biopharma Co., Ltd.), Jilin University (JLU) - First Hospital and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads
34
(1,013,342)
View PDF
Download
Abstract:
Pucotenlimab, HX008, Anti-PD-1 antibody, Melanoma, Phase II study
Feedback